| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6169903 | The Breast | 2014 | 6 Pages |
Abstract
Ovarian protection using GnRH agonists can be safely considered for young women with breast cancer in terms of oncologic outcomes. Further studies are needed to assess the long-term outcomes of concurrent GnRH agonist use with chemotherapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Jiyoung Kim, Minkook Kim, Jun Ho Lee, Hyunchul Lee, Se Kyung Lee, Soo Youn Bae, Si-Youl Jun, Won Ho Kil, Jeong Eon Lee, Seok Won Kim, Seok Jin Nam,